Delving into the Latest Updates on Neosil, Inc. with Synapse

概览

关联

1

项与 Neosil, Inc. 相关的药物

NEOSH-101

靶点-

作用机制-

在研机构-

原研机构

Neosil, Inc.

在研适应症-

非在研适应症

男性雄激素源性脱发 [+1]

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

10

项与 Neosil, Inc. 相关的临床试验

ACTRN12607000448448 / Active, not recruiting临床2期

A Phase 2 Two-Center, Randomized, Double-blind, Placebo-controlled, Paired Treatment Site Comparison Study to Evaluate the Safety and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in Reduction of Wound Bioburden among Adults Treated with Curettage & Electrodessication for Superficial Basal Cell Carcinomas of the Trunk and Extremities

开始日期2007-09-10

申办/合作机构

Neosil, Inc.

ACTRN12607000447459 / Suspended临床1/2期

A Phase 1/2 Single Center, Randomized, Double-blind, Placebo-controlled, Left-Right Comparison Study to Evaluate the Safety and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in Older Adolescents and Adults with at least Moderate Atopic Dermatitis

开始日期2007-09-10

申办/合作机构

Neosil, Inc.

ACTRN12607000267459 / Completed临床1/2期

A Phase 1/2, Single-Center, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in the Reduction or Eradication of Staphylococcus aureus Nasal Carriage among Adults

开始日期2007-06-08

申办/合作机构

Neosil, Inc.

100 项与 Neosil, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Neosil, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Neosil, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Neosil, Inc. 相关的转化医学

登录后查看更多信息